Literature DB >> 11756005

Localization of central MHC genes influencing type I diabetes.

K Y Cheong1, R J Allcock, P Eerligh, C S Witt, F T Christiansen, V McCann, P Price.   

Abstract

The contribution of MHC class II haplotypes to susceptibility to type I diabetes has been clearly established, and interest has now focused on the effects of additional genes in the MHC region. We have investigated the central MHC alleles on 8.1 ancestral haplotype (HLA-A1, B8, DR3, DQ2), as it is well conserved in Caucasian populations. The HLA-DR3-DQ2 genotype is a recognized risk factor for type I diabetes. Single nucleotide polymorphisms and microsatellites in the MHC were used to map segments of the 8.1 ancestral haplotype carried by type I diabetic and control subjects expressing either HLA-B8 or DR3, but not both these markers. In this way we controlled for the diabetogenic effect of carriage of DR3. Alleles of the 8.1 ancestral haplotype between TNFA-308/D6STNFa and HLA-B were carried with significantly greater frequency in B8(-), DR3(+) type I diabetic patients compared with B8(-), DR3(+) controls. This interval was marked by a BAT1 gene polymorphism and a MIB microsatellite allele.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11756005     DOI: 10.1016/s0198-8859(01)00351-2

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  A promoter polymorphism in the central MHC gene, IKBL, influences the binding of transcription factors USF1 and E47 on disease-associated haplotypes.

Authors:  Alvin Boodhoo; Agnes M L Wong; David Williamson; Dominic Voon; Silvia Lee; Richard J N Allcock; Patricia Price
Journal:  Gene Expr       Date:  2004

Review 2.  Type 1 diabetes mellitus and multiple sclerosis: common etiological features.

Authors:  Adam E Handel; Lahiru Handunnetthi; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Endocrinol       Date:  2009-11-03       Impact factor: 43.330

3.  Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk.

Authors:  Gaddiel Galarza-Muñoz; Farren B S Briggs; Irina Evsyukova; Geraldine Schott-Lerner; Edward M Kennedy; Tinashe Nyanhete; Liuyang Wang; Laura Bergamaschi; Steven G Widen; Georgia D Tomaras; Dennis C Ko; Shelton S Bradrick; Lisa F Barcellos; Simon G Gregory; Mariano A Garcia-Blanco
Journal:  Cell       Date:  2017-03-23       Impact factor: 41.582

4.  Association between the HLA-DRB1*03:01-DQB1*02:01 haplotype and PF4/heparin antibodies.

Authors:  Ray Zhang; Brian F Duffy; Vinzenz Lange; Charles S Eby; Chang Liu
Journal:  Blood Adv       Date:  2019-10-22

5.  Modulation of type 1 diabetes susceptibility by tumor necrosis factor alpha -308 G/A and lymphotoxin alpha +249 A/G haplotypes and lack of linkage disequilibrium with predisposing DQB1-DRB1 haplotypes in Bahraini patients.

Authors:  Mouna Stayoussef; Fayza A Al-Jenaidi; Abduljabbar Al-Abbasi; Khadija Al-Ola; Haya Khayyat; Touhami Mahjoub; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

6.  Structure of tumor necrosis factor-alpha haploblocks in European populations.

Authors:  Aimee M Merino; Kui Zhang; Richard A Kaslow; Brahim Aissani
Journal:  Immunogenetics       Date:  2013-04-12       Impact factor: 2.846

7.  Characterizing the diversity of MHC conserved extended haplotypes using families from the United Arab Emirates.

Authors:  Halima Alnaqbi; Guan K Tay; Sarah El Hajj Chehadeh; Habiba Alsafar
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.